Frankenfield Christopher James Insider Trades

Insider Trading History

Track insider trading activity for Frankenfield Christopher James. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Xilio Therapeutics
Xilio Therapeutics XLO
Chief Financial Officer
Holding Value $220k 24,766 shares
Last Trade
Jan 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$66.1k 7,030 shares
$9.40
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
Chief Financial Officer
Holding Value $283k 31,796 shares
Last Trade
Jan 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$174k 19,375 shares
$8.96
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
Chief Financial Officer
Holding Value $345k 38,750 shares
Last Trade
Jan 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$174k 19,375 shares
$8.96
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
Chief Financial Officer
Holding Value $5.95M 668,789 shares
Last Trade
Dec 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.99M 668,789 shares
$8.96
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
Chief Financial Officer
Holding Value $8.23M 925,000 shares
Last Trade
Nov 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.1M 1,618,082 shares
$10.54
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
Chief Financial Officer
Holding Value $1.38M 155,090 shares
Last Trade
Nov 21, 2025 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.63M 155,090 shares
$10.54
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Nov 21, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$7.31M 693,082 shares
$10.54
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
Chief Financial Officer
Holding Value $668k 75,000 shares
Last Trade
Apr 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$53.3k 75,000 shares
$0.71
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
Chief Financial Officer
Holding Value $111k 12,421 shares
Last Trade
Jan 02, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$6.81k 6,954 shares
$0.98
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
Chief Financial Officer
Holding Value $172k 19,375 shares
Last Trade
Jan 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$18.5k 19,375 shares
$0.96
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
Chief Financial Officer
Holding Value $2.23M 251,000 shares
Last Trade
Jan 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$241k 251,000 shares
$0.96
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
Chief Financial Officer
Holding Value $517k 58,125 shares
Last Trade
Jan 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$18.5k 19,375 shares
$0.96
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
Chief Operating Officer
Holding Value $463k 52,000 shares
Last Trade
Aug 03, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$46.8k 52,000 shares
$0.90
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
CHIEF OPERATING OFFICER
Holding Value $1.85M 208,000 shares
Last Trade
May 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$225k 208,000 shares
$1.08
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
CHIEF OPERATING OFFICER
Holding Value $690k 77,500 shares
Last Trade
Jan 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$42.6k 77,500 shares
$0.55
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
CHIEF OPERATING OFFICER
Holding Value $2.67M 300,000 shares
Last Trade
Aug 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$837k 300,000 shares
$2.79
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
Chief Operating Officer
Holding Value $0 0 shares
Last Trade
Aug 03, 2023 Sale
$668k 243,082 shares
$2.75
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
Chief Operating Officer
Holding Value $1.34M 150,000 shares
Last Trade
Aug 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$413k 150,000 shares
$2.75
$8.90

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up